chrisvoncsefalvay/vaers-outcomes huggingface dataset:
3.5 days after vaccine I woke up in the middle of the night with shooting electric pains all down my left arm and a completely numb left arm, extreme pins and needles throughout body and electric feeling, skin crawling and involuntary movements throughout body, symptoms subsided after about an hour, after 24 hours got deep pain in shoulder and down entire arm, then the arm gave out and I put it in a sling, arm has regained full functionality but the top part of my arm around the injection site is still weak, twitchy, and feels strange and uncomfortable
1/13/21- tingling and numbness in lips, tongue, mouth 1/16/21- 1/19/21 swollen right upper eyelid  1/22/21- present red, itchy rash on tops and bottoms of finger and toe joints as well as elbows. Swollen and inflamed right big toe
2 x 3" warm, indurated area (L) deltoid and 6 x 7" red, warm indurated area (R) upper arm. Tx - recheck if fever, increased pain or decreased use of arm. Advised should improve without tx over next 2-4 d.
Patient admitted on date at 36w3d for preterm labor, and underwent primary low transverse cesarean section due to breech presentation without complications. This visit was within 6 weeks of receiving the COVID vaccine.
Fever 100.8 Chills Dizziness Mild nausea Dizziness Missed two days work. Feeling better, expect to return to work tomorrow.
I had all the symptoms I had with COVID-19 virus, plus a swollen arm that was hot to touch, sore and swollen. My arm was heavy and abnormal feeling.
body shooting pain; This is a spontaneous report from a contactable consumer (patient). A 44-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: ER8730), intramuscular in right arm on 19Mar2021 13:00 (at the age of 44-years-old) as dose 1, single for COVID-19 immunization. Medical history included Congestive heart failure (CHF) congenital from 14Jun1976 and ongoing (medication maintained) and chronic obstructive pulmonary disease from 2004 and ongoing (nebulizer inhaler). The patient's concomitant medications were not reported. The patient experienced body shooting pain (medically significant) on 20Mar2021 06:00. No treatment was received for the event. Outcome of event was resolved on 30Mar2021.  No follow-up attempts are possible. No further information is expected.
Pain at the injection site was nearly immediate. I still have significant swelling and soreness as of 11:07am CST on 2/26/21 Diarrhea from 4:30pm to 7:30pm on 2/24/21 Chills and fever started at 2:00am on 2/25/21 and ended at 3:00am on 2/26/21 Body aches, joint pain, headache started at 6am on 2/25/21 and ended at around 3:00am on 2/26/21
No other AE reported; temperature excursion; This spontaneous report was received from a medical assistant and refers to a 11-day-old male patient. There was no information about the patient's concurrent conditions, allergies, drug reactions, concomitant therapies or medical history provided. On 28-SEP-2020, the patient was vaccinated with improperly stored hepatitis b vaccine (recombinant) (RECOMBIVAX HB) via intramuscular route of administration (lot# reported as R028259 which was verified to be non valid with expiration date 20-JUN-2021 lot was also reported as #R028529 verified to be valid, expiration date: 09-JUN-2021) (exact dose, dose number, route of administration and anatomical location were not reported) for prophylaxis. Other suspect therapies included improperly stored rotavirus vaccine, live, oral, pentavalent (ROTATEQ) via oral route of administration (lot# 1660989 was confirmed to be valid, expiration date was reported as 20-JUN-2021 and 15-MAY-2021, but upon internal validation was established as 15-APR-2021) (exact dose, dose number, anatomical location were not reported) for prophylaxis. The temperature to which the vaccines were exposed was from 43.4 (low temperature, degrees not reported) to 60.4 (high temperature) degrees of Fahrenheit (F) and the time frame was reported as 665.83 hours (first date when the product was out of proper storage range was reported as 01-AUG-2020, but noone did not know about it until the reporting time). No previous temperature excursion was reported. A digital data logger was involved. No adverse symptoms were reported.
24-48 hrs after injection swelling & erythema (R) hand & both elbows. Wheals & urticaria. Fussiness about 24-48 hrs after injection.
A chest x-ray showed some inflammation on the lungs; Slight pain in her arms after taking the vaccine; Bad headache; She started to develop a cough after the injection that did not improve and had worsened by the end of the second week; This is a spontaneous report from a contactable Nurse (reporting for herself). A 62-year-old female patient started received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, batch/lot no. and expiry date: unknown), via an unspecified route of administration on 18Dec2020 at a single dose for an unspecified indication. The patient's medical history and concomitant medications were not reported.  As reported, patient asked, "should I get the second injection of the COVID-19 vaccine since I have this cough that will not go away?." This female nurse, who was also the patient, reported receiving her first injection of the PFIZER COVID-19 VACCINE on 18Dec2020. She started to develop a cough after the injection that did not improve and had worsened by the end of the second week. Treatment has included cetirizine (ZYRTEC), dextromethorphan (ROBITUSSIN),Guaifenesin (MUCINEX) and albuterol inhaler. A chest x-ray showed some inflammation on the lungs and she was given a steroid inhaler, which has helped. She has received two COVID-19 tests at different time intervals, and both were negative. She was scheduled to receive the second COVID-19 vaccination on Friday but was uncertain if she should receive it given her cough was not improving. She had a bad cough, and other symptoms just before her injection (pending clarification). But her general practitioner (GP) put her in a steroid inhaler. She talked to her GP but can't give her complete advice as to whether she can still take the 2nd dose or not due to her situation. She said she had very slight pain in her arms after taking the vaccine, and felt a really bad headache on 18Dec2020. She would like to know if she still needs to continue the 2nd dose of vaccine or not since she still has a cough. Patient asked if there was any guidance on getting a second dose and what if test was a false positive and she really did have COVID-19?. Outcome of the event "She started to develop a cough after the injection that did not improve and had worsened by the end of the second week" was  not recovered while "A chest x-ray showed some inflammation on the lungs", Slight pain in her arms and Bad headache were unknown.   Information on the Batch/Lot number has been requested.
Husband called to report client experienced nausea, severe headache after flu shot, lasting approximately 3 days.
on March 28th I was diagnosed with covid19. The same day I went for the bam treatment at Hospital.  On April 7th I was diagnosed with covid pneumonia
pt recv vax 19APR96 & 4DEC97 pt presented w/approx 10 crusty lesions on trunk & neck;
Began oral typhoid on Wed 03/30/05 in AM 1 hr after taking pill, began with diarrhea/vomiting, had diarrhea continuously until taking 2nd dose on Fri 4/1/05 after second dose symptoms worsened. Client spike a temp of 103 Friday evening no improvement of diarrhea vomiting resolved. Ct traveled earlier in month of March. States felt well until taking the oral typhoid. 1 ER visit for fluids. Client still with diarrhea, encouraged further follow up with MD. Symptoms also reported to Manf.
Patient reported to the site having previously received Moderna (17 May, LOT 026C21A) at another military location.  The front door screeners overlooked his vaccination card information and allowed him to enter the facility.  The card was not presented to the administrative evaluator of the DHA and was not requested by this evaluator either.  Patient made it to the secondary verification and stated he was here for his second Pfizer dose.  He was directed to a vaccine table where he received a dose of Pfizer.  At the check-out table it was recognized that he had previously received Moderna.  This was brought to my attention immediately.  I counseled the patient regarding mixing of the vaccines specifically focusing on the lack of data showing the overall efficacy of such mixing.  I informed him he may receive additional phone calls/emails regarding this incident.  Patient noted no concerning symptoms post vaccine and had no questions or concerns.
On 12/07/2022 the patient was administer the COVID19 vaccine as a booster. (Bivalent vaccine should have been used for booster dose)
other zoster-related conditions; shingles; Information has been received from a lawyer and a patient of unknown age and gender regarding a case in litigation. Information about concurrent condition, medical history and concomitant medication was not reported. In or about 2015, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (strength, dose, lot#, expiration date and route unknown) for the long-term prevention of shingles and zoster-related conditions by a pharmacist. Subsequent to the inoculation (date not reported), the patient was treated by health providers for shingles and other zoster-related conditions. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient has and will continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future. The outcome of the event shingles and other zoster-related conditions was not recovered. The causality assessment was considered as related by the lawyer.
On the evening after the vaccinations were administered, patient claims to have felt itchiness in the upper left arm and that it was swollen and red. By the next day (9/26/2017) she claims that beside the itching, she felt extreme pain (9 on a scale of 1 to 10). She said that she took a Benadryl. Patient came in today to report this adverse reaction and showed the pharmacist on duty her arm, which appeared red and swollen. She claims the pain is still around 8 or 9. Patient was advised to take Benadryl again this evening, along with a Pepcid and some Advil and use an ice pack. Pharmacy staff will follow up with patient's condition tomorrow morning.
I was sick with flu like symptoms that lasted two weeks. It was dizziness that started at the beginning of January. I had a fever, achiness and headache. I was off balance all of the time. The doctor did look in my ears and saw what looked like a ear infection. The other issue was my kidney numbers were off, I'm scheduled to see a specialist soon. This was not at the same time about the kidney information. She repeated it a few times at other appointments. I was given an antibiotic for the ear infection and since then my balance has gotten better. Now I feel the dizziness is better not totally gone. I did have three negative COVID-19 tests. Those symptoms of the flu are gone, the unsteady and lack of balanced lasted beyond the other symptoms.
This case was received from a consumer in the United States on 13 August 2007. A 41-year-old female patient with a history of asthma, seasonal allergies, penicillin allergy, and varicose veins, received a right deltoid injection of Decavac (lot number U1953U) on 08 July 2007 for a "dirty wound". Two days later, on 10 July 2007, she began experiencing sharp pain in the left lower back, left eye "fuzzy", severe spasms and leg cramping in bilateral calves, headache, diarrhea, nausea, and feeling "throat closing". She presented to the emergency room, and was treated with steroids and nexium. She also required a doctor visit. At the time of the report, the events were still ongoing.
Dizziness, Nausea, Exacerbation of arthritis pain, one severe episode of vertigo, headaches
SNEEZING; DRY COUGHING; This spontaneous report received from a consumer concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient had not been infected with Covid in the past. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced sneezing, and dry coughing. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sneezing, and dry coughing. This report was non-serious. This case, from the same reporter is linked to 20210661153.
Chills, low grade fever (99.9), fatigue, rash (red stripes, almost like finger sized rash). Took Tylenol. Fever, chills and fatigue lasted 2 days, rash only lasted one day.
Tingling in L hand (same side she received the vaccine) about 5 minutes after vaccine.
Patient was vaccinated at 12:27PM, presented to the post-vaccination observation area and informed staff that she had prior reactions to the first dose.  12:38PM ? Patient started to experience flushing and warmth on neck and ears. Slight redness noted on area. 12:40PM ? Patient reported visual changes. Stated: ?Everything looks brighter than normal. I constantly have to readjust my focus.? Benadryl 12.5mg chewable offered. Patient declined and stated that she gets drowsy on medication and had taken two (2) the night before vaccination. 12:50PM ? Patient report itching on both sides of torso, vital signs taken BP- 119/76 SPO2-99% HR-68 1:00PM ? Patient reported itching has started on head, Benadryl offered and declined. Patient was offered to take Benadryl to have on hand. Patient agreed and stated she would take one once she is halfway home. 1:05PM ? Patient reported some itching in between thighs, declined to have it looked at in bathroom. Instructed patient to take Benadryl on the way home ? patient agreed. Educated patient to stay hydrated, take a Motrin/Tylenol if expected signs and symptoms are experienced. Instructed patient to check in with nurse (Contact # given) once she arrives home. 1:28PM ? Patient contacted nurse via text, stated that she was home. Still feeling flushed and was going to lay down.
a small knot on his cheek with the first shot; This is a spontaneous report from a contactable consumer or other non hcp (patient). A male patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection) via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced a small knot on his cheek with the first shot. Patient reclarifies, that with the first shot, he had a small knot on his cheek, but with the second vaccine the knot is bigger and also stated he is breathing funny today. He inquired what should he do about the knot on his cheek. The outcome of the event was unknown.   The lot number for the vaccine [BNT162B2] was not provided and will be requested during follow up.
Inadvertently provided 2nd dose early. 2nd dose should have been administered 8/26 but administered 8/23. Patient was monitored for 30 minutes (rather than 15 minutes) with no issues. (English was not the patient's first language which contributed to  error.)
REDNESS ON THE ARM WHERE VACCINE SHOT WAS GIVEN, ITCHINESS, SWELLING - SEVERAL DAYS
Circulatory issues in right lower leg resulting in significant swelling of right ankle for two days.
Clients mother reports he had a seizure the day following administration of second dose and  he developed extreme shaking and thrashing around while she was caring for him and he was lying on his side. The episode lasted for 30 seconds to 1 minute and he slept for about half an hour afterward. He has since been more subdued and listless but is beginning to display more of his typical behaviors again. She said he has had milder seizure like activity in past when his head tilts backward and he has stiffness and staring with last episode of this being 6 months ago. Last grand mal seizure occured when he was young and related to issues with his shunt.
Chest pain x 3 days, dx'd as pericarditis secondary to vaccine administration.
This spontaneous report received from a consumer via a company representative via social media concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, 1 total, start therapy date was not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient died. It was reported as "Patient my dad did too" (It was in response to the previously reported event, "My mom died 2 days after getting the vaccine"). It was unspecified if an autopsy was performed or not. The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death). Sender's Comments: V0: 20220308262-Covid-19 vaccine ad26.cov2.s -Died. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). Therefore, this event(s) is considered unassessable. Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH.
pt recvd vax; devel approx 50-70 lesions by 21oct95;
Area of arm from deltoid muscle to top of elbow joint reddened, warm and indurated. No fever. Minimal complaints of soreness.
Information has been received from a registered nurse (RN) concerning an approximately 9 week old female with gastroesophageal reflux, milk, soy and protein intolerance who on 22-SEP-2008 was vaccinated PO with the first 2.0 ml dose of ROTATEQ (lot # 661037/0641X). Concomitant therapy included (ZANTAC). On an unspecified date between 22-SEP-2008 and 25-SEP-2008, the registered nurse reported that the patient's mild, soy and protein intolerance was aggravated after receiving the first dose of vaccine. The patient's symptoms were described as "colicky". No treatment was reported. The RN reported that the patient sought medical attention with a phone call. The outcome was reported as not recovered / not resolved. A product quality complaint was not involved. Additional information has been requested.
Fever / Fever 100 and I am normally 97; severe chills; muscle aches all over; HA; back pain; neck pain; and tired; left inner thigh is sensitive to touch; This case was reported by a consumer and described the occurrence of fever in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On 11th June 2021, the patient received the 1st dose of Shingles vaccine. In June 2021, less than a week after receiving Shingles vaccine, the patient experienced fever, chills, generalized muscle aches, headache, back pain, neck pain, tiredness and touch sensitivity increased. On an unknown date, the outcome of the fever, chills, generalized muscle aches, headache, back pain, neck pain, tiredness and touch sensitivity increased were unknown.   It was unknown if the reporter considered the fever, chills, generalized muscle aches, headache, back pain, neck pain, tiredness and touch sensitivity increased to be related to Shingles vaccine.  Additional details were provided as follows: The patient self reported the case. The age at vaccination was not reported. The patient received dose of Shingles vaccine and experienced Fever, severe chills , muscle aches all over, headache, back pain, neck pain and tired, fever 100 and patient normally 97 degree F. The patient left inner thigh was sensitive to touch . The reporter consent to follow up.
Angioedema (swelling of throat); no treatment; swelling resolved 4 hours after start; event was not reported to a health care facility until patient arrived for 2nd shot
About 5 min after giving the vaccine, patient complained of not feeling well.  Symptoms included headache, loss of sensation in arms, light headedness.  Patient appeared pale, and confused.  Attempted to have patient stand up and walk to counsel room opposite where she was sat.  After standing, she immediately sat down, and fainted while she was seated.  Pharmacist supported her head, and her boyfriend/significant other prevented her from falling off the chair.  Patient was momentarily unresponsive for about 3 seconds.  During this time her eyes remained open.  Once patient regained consciousness, walked her to counsel room and had her lie down on her back with her legs elevated on a chair.  Blood pressure was within normal limits.  Patient was feeling better in about 10 minutes, and continued to monitor for another 5.  Gave water to sip on, and no additional adverse effects noted.
This spontaneous report was received from a physician via a company representative refers to a 82-year-old male patient. On an unknown date in December 2010 The patient was vaccinated with a dose of ZOSTAVAX (lot# and expiration date not reported) subcutaneously. While on ZOSTAVAX the patient developed shingles on 28-JAN-2013. The patient was prescribed VALTREX. It was unspecified whether lab diagnostic studies were performed. The patient sought medical attention for the event. The outcome of "shingles' was unknown at the time of this report. Additional information is not expected.
Headache and injection site pain; Headache and injection site pain; This is a spontaneous report from a contactable consumer.  An approximately 40 year old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on 17Dec2020 (at the age of 40 years-old) as a single dose for COVID-19 vaccination. Medical history was unknown. The patient's concomitant medications were not reported. On an unknown date, the patient experienced injection site pain and headache. The clinical outcome of injection site pain and headache was unknown.    No follow up attempts are possible; information about lot/batch number cannot be obtained.
pt stated when she bled when she was given the covid vax and was told that it may have gotten in her veins.  She woke up the next day with a rush of light headiness and dizziness that she still has to this day.  She said her blood pressure is normal so she has contacted her PCP yet but will call them to let them know.
PT BEGAN TO EXPERIENCE CONSTANT VOMITING AND RASH AFTER ABOUT 30-45 MINUTES AFTER RECEIVING VACCINE.